San Francisco, CA, United States of America

Eric Shifrut

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Eric Shifrut in T Cell Receptor Engineering

Introduction

Eric Shifrut is a prominent inventor based in San Francisco, CA, known for his significant contributions to the field of immunology and genetic engineering. With a total of five patents to his name, he has made remarkable strides in the targeted editing of T cell receptors, which has implications for cancer therapy and other medical applications.

Latest Patents

Among his latest patents is the innovative method for the targeted replacement of endogenous T cell receptors. This patent outlines methods and compositions for editing the genome of human T cells. In particular, it describes the insertion of a heterologous T cell receptor (TCR)-β chain and a heterologous TCR-α chain into exon 1 of a TCR subunit constant gene within the T cell genome. This groundbreaking work aims to enhance the efficacy of T cell therapies.

Career Highlights

Eric Shifrut is affiliated with the University of California, where he conducts research that bridges the gap between genetic engineering and therapeutic applications. His work has garnered attention for its potential to revolutionize treatments for various diseases, particularly in the realm of immunotherapy.

Collaborations

Some of his notable coworkers include Theodore Lee Roth and Alexander Marson, who collaborate with him on various research projects aimed at advancing the field of T cell engineering.

Conclusion

Eric Shifrut's innovative work in T cell receptor engineering exemplifies the potential of genetic editing in modern medicine. His contributions are paving the way for new therapeutic strategies that could significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…